{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:51:04Z","timestamp":1791215464377,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002329","name":"Bundesamt f\u00fcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijid.2026.108870","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T05:47:15Z","timestamp":1780811235000},"page":"108870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Primary bedaquiline-resistant tuberculosis in an Afghan migrant to Switzerland: Diagnostic and treatment challenges in a high-resource setting"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6400-1414","authenticated-orcid":false,"given":"Nasstasja","family":"Wassilew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Eichenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Staehelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Schulthess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunar","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108870_sbref0001","series-title":"WHO consolidated guidelines on tuberculosis: Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update","year":"2022"},{"issue":"1","key":"10.1016\/j.ijid.2026.108870_bib0002","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1186\/s12879-025-11067-2","article-title":"Prevalence of bedaquiline resistance in patients with drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"25","author":"Hu","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"20","key":"10.1016\/j.ijid.2026.108870_bib0003","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMc1505196","article-title":"Acquired resistance to bedaquiline and delamanid in therapy for tuberculosis","volume":"373","author":"Bloemberg","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijid.2026.108870_bib0004","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3201\/eid3003.240134","article-title":"Bedaquiline resistance after effective treatment of multidrug-resistant tuberculosis, Namibia","volume":"30","author":"Gunther","year":"2024","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2026.108870_bib0005","first-page":"684","article-title":"Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline","volume":"72","author":"Villellas","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.ijid.2026.108870_bib0006","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5588\/ijtld.22.0536","article-title":"Primary bedaquiline resistance in Karakalpakstan, Uzbekistan","volume":"27","author":"Moe","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108870_bib0007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-024-01289-5","article-title":"Detection of a historic reservoir of bedaquiline\/clofazimine resistance-associated variants in Mycobacterium tuberculosis","volume":"16","author":"Nimmo","year":"2024","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.ijid.2026.108870_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00019-21","article-title":"Intragenic distribution of IS6110 in clinical mycobacterium tuberculosis strains: bioinformatic evidence for gene disruption leading to underdiagnosed antibiotic resistance","volume":"9","author":"Antoine","year":"2021","journal-title":"Microbiol Spectr"},{"issue":"2","key":"10.1016\/j.ijid.2026.108870_bib0009","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1016\/S2666-5247(23)00317-8","article-title":"Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysis","volume":"5","author":"Nimmo","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijid.2026.108870_bib0010","unstructured":"WHO Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, 2nd ed https:\/\/www.who.int\/publications\/i\/item\/9789240082410. Geneva 2023."},{"key":"10.1016\/j.ijid.2026.108870_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.870768","article-title":"Tuberculosis phenotypic and genotypic drug susceptibility testing and immunodiagnostics: a review","volume":"13","author":"Yusoof","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ijid.2026.108870_bib0012","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1164\/rccm.201902-0260LE","article-title":"New World Health Organization treatment recommendations for multidrug-resistant tuberculosis: are we well enough prepared?","volume":"200","author":"Kranzer","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ijid.2026.108870_bib0013","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa2400327","article-title":"Oral regimens for rifampin-resistant, fluoroquinolone-susceptible tuberculosis","volume":"392","author":"Guglielmetti","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108870_sbref0014","series-title":"WHO consolidated guidelines on tuberculosis: Module 4: treatment and care","year":"2025"},{"key":"10.1016\/j.ijid.2026.108870_bib0015","article-title":"Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study","volume":"56","author":"Kherabi","year":"2025","journal-title":"Lancet Reg Health Eur"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:52:54Z","timestamp":1791211974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226005059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":15,"alternative-id":["S1201971226005059"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108870","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary bedaquiline-resistant tuberculosis in an Afghan migrant to Switzerland: Diagnostic and treatment challenges in a high-resource setting","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108870"}}